ON Semiconductor Corp. (ON) Misses Q4 Earnings and Revenue Estimates — Negative

ON   Zacks Investment Research — February 10, 2025

ON Semiconductor Corp. (ON) came out with quarterly earnings of $0.95 per share, missing the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.25 per share a year ago.

image for news ON Semiconductor Corp. (ON) Misses Q4 Earnings and Revenue Estimates

Intel: It's Time To Let Go — Negative

INTC   Seeking Alpha — February 10, 2025

Intel has lost 65% in value since 2021 and has suspended its dividend. Intel's core x86 CPU business is losing market share to AMD, while Intel's gross margin is also far behind its peers. Intel's new leadership faces urgent decisions to avoid falling further behind competitors like AMD, NVIDIA, and TSMC in key growth markets.

image for news Intel: It's Time To Let Go

CHICAGO, IL / ACCESS Newswire / February 10, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Dimitris Moraitis as Vice President of Strategy & Operations. Mr. Moraitis brings over 25 years of experience in strategic planning, operations, and business development within the pharmaceutical sector.

image for news Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Is Costco Wholesale Stock a Buy, Sell, or Hold in 2025? — Positive

COST   The Motley Fool — February 10, 2025

Bulk-buying, bargain-hunting shoppers propelled Costco Wholesale (COST -0.57%) to a record-breaking 2024 for sales and earnings. The discount retailer is benefiting from a resilient economic backdrop while capitalizing on an ongoing e-commerce expansion.

image for news Is Costco Wholesale Stock a Buy, Sell, or Hold in 2025?

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128404&wire=1 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by March 25, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)

RADNOR, PA / ACCESS Newswire / February 10, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ:CROX) ("Crocs" or the "Company") on behalf of investors who purchased or otherwise acquired Crocs common stock between November 3, 2022, and October, 28 2024, inclusive (the "Class Period"). This action, captioned Carretta v.

image for news Lead Plaintiff Deadline Approaching in CROX: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Against Crocs, Inc.

3 Reasons to Love This Underperforming Chipmaker — Neutral

QCOM   MarketBeat — February 10, 2025

Shares of tech giant Qualcomm Inc. NASDAQ: QCOM have been stuck in a holding pattern for months, but recent signs point to a shift in momentum. After a largely sideways trend since July, the stock has gained 10% since December.

image for news 3 Reasons to Love This Underperforming Chipmaker

Take-Two Interactive chairman and CEO Strauss Zelnick joins 'Squawk Box' to discuss the company's quarterly earnings results, state of gaming, gaming release pipeline, regulatory and M&A outlook under the new Trump administration, latest news on Grand Theft Auto VI, impact of AI on gaming, and more.

image for news Take-Two Interactive CEO Strauss Zelnick on Grand Theft Auto VI: We couldn't be more excited

The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities. The report covers Walmart's US sales trends and e-commerce performance from fiscal years 2019 to 2024, and provides estimates of Walmart's US grocery market share from 2021 to 2024. It analyzes the reasons behind and implications of shifts in consumer perceptions and behaviors, highlighting future market opportunities.

image for news Walmart Grocery Market Share to Increase with Rising Demand for Digital Shopping and Value-Oriented Options

2 Stocks to Shield Your Portfolio from AI and Tech Froth — Neutral

PM  XOM   MarketBeat — February 10, 2025

In the current state of the stock market, investors argue over whether valuations are too high. Some see historical indicators as signs of doom, while others feel that future earnings will justify prices.

image for news 2 Stocks to Shield Your Portfolio from AI and Tech Froth

Powerfleet Reports Third Quarter 2025 Financial Results — Neutral

AIOT   PRNewsWire — February 10, 2025

Q3 revenue rises to $106 million, an increase of 45% year-over-year, with service revenuerepresenting 77% of total revenue Adjusted EBITDA climbs to $22 million, an increase of 77%, driving an annual run ratesurpassing $85 million— doubling 2024 adjusted EBITDA FY25 full year guidance increased $10 million for revenue and $2.5 million for adjustedEBITDA Meaningful increase in adjusted gross margin performance, with total adjusted grossmargins now above 60%, and adjusted service gross margins approaching 70% Post-M&A integration ahead of schedule, priming for double digit growth trajectory in FY26 WOODCLIFF LAKE, N.J. , Feb. 10, 2025 /PRNewswire/ -- Powerfleet, Inc. (Nasdaq: AIOT) …

image for news Powerfleet Reports Third Quarter 2025 Financial Results

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ATRA.

image for news Atara Biotherapeutics, Inc. (ATRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Hydrofarm Announces Reverse Stock Split — Neutral

HYFM   GlobeNewsWire — February 10, 2025

SHOEMAKERSVILLE, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (Nasdaq: HYFM) (“Hydrofarm” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, par value $0.0001, which will be effective at 5:00 pm Eastern Time on February 12, 2025. The Company's common stock will continue to be traded on The Nasdaq Capital Market on a split-adjusted basis beginning on February 13, 2025, under the Company's existing trading symbol “HYFM.”

image for news Hydrofarm Announces Reverse Stock Split

Guardant Health to Participate in Upcoming Investor Conferences — Neutral

GH   Business Wire — February 10, 2025

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BTIG 12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, UT Hosting 1x1 meetings on Tuesday, February 11th and Wednesday, February 12th TD Cowen 45th Annual Health Care Conference in Boston, MA Fireside chat on Tuesday, March 4th at 10:30 a.m. Eastern Tim.

image for news Guardant Health to Participate in Upcoming Investor Conferences

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TELUS securities between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period").

image for news TIXT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that TELUS International (Cda) Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.

image for news Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025

MIAMI, FL / ACCESS Newswire / February 10, 2025 / The recent executive order banning paper straws in the United States marks a pivotal shift in sustainability policy. While well-intentioned, the push for alternatives like Paper Pulp and new chemistry for plastics has been proven problematic and with significant commercial challenges -prone to breaking down, leaving a poor user experience, and requiring resources that aren't always greener.

image for news Plastic is Here to Stay-SMX Technology Allows Us to Be Responsible About It

First Jointly Developed AI Agent Helps Customers Maximize Cisco Investments and Boosts Productivity News Summary: Powerful Partnership: The first of several AI agents being developed by Cisco with Mistral AI as a strategic technology partner, to help drive Cisco's Customer Experience (CX) move towards an Agentic-AI-Led future. AI-Powered Efficiency: The AI Renewals Agent streamlines and enhances the creation process for Cisco's Renewals team by analyzing data from 50 sources to build custom proposals tied to customer outcomes.

image for news Cisco and Mistral AI Partner to Deliver on Cisco's Mission to Transform the Customer Experience with AI

Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer — Neutral

IOVA   GlobeNewsWire — February 10, 2025

SAN CARLOS, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that Dan Kirby will join the Company's executive leadership team in the newly created role of Chief Commercial Officer, effective today.

image for news Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer

NEW YORK CITY, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava" or "the Company") (NASDAQ:SAVA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Cassava securities between February 7, 2024 and November 24, 2024, both dates inclusive (the "Class Period").

image for news FINAL REMINDER SAVA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Cassava Sciences, Inc. Investors to Participate in the Class Action Lawsuit